CAMS stock news on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|12 matching stories

CAMS Share Price, Latest News & Sentiment

Latest AI-analyzed news for CAMS, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

CAMS News Today

Widely covered stock

The Indian pharma sector is currently experiencing mixed signals; while some segments show growth potential, US-facing pharma faces specific headwinds like pricing pressure and regulatory scrutiny. This makes selective investment crucial.

Coverage
12
recent stories
Sources
5
distinct publishers
Bias Split
9 bullish / 0 bearish
3 neutral stories
Window
89d
recent coverage span
Saved Quote Snapshot

CAMS

Last Updated
23 May 2026
Price
NA
NA
52W Range
NA - NA
exchange snapshot
PE / VWAP
PE NA
VWAP NA
Trend Read
mixed
EMA stack mixed
Business Context
Industry: NA
Sector Trail: NA
Listing Date: NA
Market Structure
F&O Eligible: No
Indices: NA
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 31 Dec 2024

Consolidated results
What This Quarter Says

This is CAMS's latest financial report. The company made ₹369.74 crore in sales and ₹124.11 crore in profit. This information is on record. These numbers show how much money the company made and kept.

Revenue
Rs 369.74 cr
up 6.4% vs previous filing
Profit
Rs 124.11 cr
up 5.3% vs previous filing
EPS / Finance Cost
EPS 25.45
Finance cost Rs 2.15 cr
Filing Context
Filed 29 Jan 2025, 8:06 pm
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 369.74 cr, up 6.4% vs previous filing.
  • Profit this quarter: Rs 124.11 cr, up 5.3% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 25.45.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

CAMS FAQ

Why is CAMS in the news right now?

CAMS has appeared across 12 recent stories from 5 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is CAMS coverage bullish or bearish right now?

CAMS coverage is currently leaning bullish, with 9 bullish, 0 bearish, and 3 neutral analyzed stories in the recent window.

Which themes are moving with CAMS?

Recent CAMS coverage is clustering around Financial Services and Information Technology. Related names showing up alongside CAMS include CDSL, BSE, HDFCAMC.

How should I use this CAMS news page?

Use this page as a coverage hub for CAMS: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use CAMS coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi
For pharma, focus on domestic-oriented players or those with strong product pipelines and clear regulatory approvals, avoiding broad exposure to US-facing segments due to fund avoidance signals.|Quick check: ADANIENT neutral (+0.3% 1d), DIXON neutral (+2.1% 1d).
et_marketsabout 1 month ago

Gainers & Losers: Tata Technologies, Meesho among 5 big movers on Tuesday

The FMCG sector is currently under scrutiny regarding urban vs. rural demand dynamics and margin outlook. While some reports suggest a healthy Q4FY26 performance, the broader market's selling in consumer stocks indicates potential near-term challenges.

For FMCG, maintain a neutral to cautious bias; look for companies with strong rural penetration or premiumization strategies that can offset broader demand slowdowns. Consider long positions in specific stocks showing resilience or positive earnings surprises.|Quick check: TATACHEM bullish bias (overbought), CAMS bullish bias (+9.3% 1d).

Latest CAMS Stock Coverage

Look for long opportunities in smallcap stocks with strong earnings and positive technical momentum, maintaining strict stop-losses due to overall market volatility.|Quick check: WOCKPHARMA bullish bias (+2.8% 1d), TATASTEEL neutral (+0.4% 1d).
Accumulate exchange/market-infra peers (BSE, CDSL, MCX) ahead of NSE listing as sector re-rating likely; large OFS may temporarily absorb primary market liquidity.
Market has likely priced this in; hold off on aggressive longs in pure-play payments names, and only add exposure to large lenders after RBI’s final circular confirms exemptions that protect user-friendly high-value transfer flows.
Consider accumulating quality Indian financial stocks, particularly private banks and well-managed NBFCs, on dips, as institutional interest signals improving fundamentals.
Given the article's age and the indirect nature of the impact, market participants have likely priced in general aviation disruptions; focus on direct news concerning Indian carriers.
Market has likely priced in the general trend of global diversification; focus on Indian financial intermediaries facilitating this trend for potential long-term upside.
Consider long positions in Indian asset management companies and financial technology providers that are well-positioned to capitalize on the shift towards systematic active investing.